Markowski Investments’s Bristol-Myers Squibb BMY Stock Holding History

Markowski Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$90.4K	Buy	+1,569	New	+$90.1K	0.02%	166

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Markowski Investments's BMY Position: Q2 2026 in Review

Markowski Investments opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 1,569 shares worth $90.4K. The stake represents 0.02% of the portfolio and ranks #166 among its holdings.

2,142 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Markowski Investments held 1,569 shares of Bristol-Myers Squibb worth $90.4K as of Q2 2026.
Bristol-Myers Squibb was a new Markowski Investments position in Q2 2026.
Bristol-Myers Squibb made up 0.02% of Markowski Investments's portfolio in Q2 2026, its #166 holding.
2,142 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.